{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:30:16Z","timestamp":1790098216599,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12899-2","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T08:46:51Z","timestamp":1771231611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Carbapenem-resistant Gram-negative bacteremia in a medical intensive care unit: predictors, antimicrobial susceptibilities, and its effects on mortality"],"prefix":"10.1186","volume":"26","author":[{"given":"Guo","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"12899_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/cid\/ciw741","volume":"64","author":"PD Tamma","year":"2017","unstructured":"Tamma PD, Goodman KE, Harris AD, Tekle T, Roberts A, Taiwo A, Simner PJ. Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase- producing carbapenem-resistant Enterobacteriaceae bacteremia. Clin Infect Dis. 2017;64:257\u201364.","journal-title":"Clin Infect Dis"},{"key":"12899_CR2","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.cmi.2016.09.003","volume":"23","author":"SM Bartsch","year":"2017","unstructured":"Bartsch SM, McKinnell JA, Mueller LE, Miller LG, Gohil SK, Huang SS, Lee BY. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the united States. Clin Microbiol Infect. 2017;23:e9\u201316.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"12899_CR3","doi-asserted-by":"publisher","first-page":"dlad076","DOI":"10.1093\/jacamr\/dlad076","volume":"5","author":"M Fatima","year":"2023","unstructured":"Fatima M, Dodani SK, Babar ZU, Badlani S, Rani B, Mushtaq M, Nadeem A, Nasim A. Outcome, risk factors and therapeutic strategies in carbapenem-resistant Gram-negative bacteraemia from Pakistan. JAC Antimicrob Resist. 2023;5(3):dlad076.","journal-title":"JAC Antimicrob Resist"},{"key":"12899_CR4","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1473-3099(18)30792-8","volume":"19","author":"AJ Stewardson","year":"2019","unstructured":"Stewardson AJ, Marimuthu K, Sengupta S, Allignol A, El-Bouseary M, Carvalho MJ, Hassan B, Delgado-Ramirez MA, Arora A, Bagga R, et al. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study. Lancet Infect Dis. 2019;19:601\u201310.","journal-title":"Lancet Infect Dis"},{"key":"12899_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jiph.2018.08.002","volume":"12","author":"C Li","year":"2019","unstructured":"Li C, Li Y, Zhao Z, Liu Q, Li B. Treatment options and clinical outcomes for carbapenem-resistant Enterobacteriaceae bloodstream infection in a Chinese university hospital. J Infect Public Health. 2019;12:26\u201331.","journal-title":"J Infect Public Health"},{"issue":"11","key":"12899_CR6","doi-asserted-by":"publisher","first-page":"750","DOI":"10.4103\/0972-5229.144021","volume":"18","author":"R Porwal","year":"2014","unstructured":"Porwal R, Gopalakrishnan R, Rajesh NJ, Ramasubramanian V. Carbapenem resistant Gram-negative bacteremia in an Indian intensive care unit: A review of the clinical profile and treatment outcome of 50 patients. Indian J Crit Care Med. 2014;18(11):750\u20133.","journal-title":"Indian J Crit Care Med"},{"issue":"5","key":"12899_CR7","first-page":"530","volume":"64","author":"K Kalam","year":"2014","unstructured":"Kalam K, Qamar F, Kumar S, Ali S, Baqi S. Risk factors for carbapenem resistant bacteraemia and mortality due to gram negative bacteraemia in a developing country. J Pak Med Assoc. 2014;64(5):530\u20136.","journal-title":"J Pak Med Assoc"},{"key":"12899_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cmi.2020.10.016","volume":"27","author":"ZR Palacios-Baena","year":"2021","unstructured":"Palacios-Baena ZR, Giannella M, Manissero D, Rodr\u00edguez-Ba\u00f1o J, Viale P, Lopes S, Wilson K, McCool R, Longshaw C. Risk factors for carbapenem-resistant Gram-negative bacterial infections: a systematic review. Clin Microbiol Infect. 2021;27:228\u201335.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"12899_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12879-020-05131-2","volume":"20","author":"DH Shin","year":"2020","unstructured":"Shin DH, Shin DY, Kang CK, Park S, Park J, Jun KI, Kim TS, Koh Y, Hong JS, Choe PG, et al. Risk factors for and clinical outcomes of carbapenem non-susceptible gram negative bacilli bacteremia in patients with acute myelogenous leukemia. BMC Infect Dis. 2020;20(1):404.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"12899_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jmii.2016.08.022","volume":"51","author":"SW Ting","year":"2018","unstructured":"Ting SW, Lee CH, Liu JW. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative Bacillus bacteremia: A retrospective propensity-matched case control study. J Microbiol Immunol Infect. 2018;51(5):621\u20138.","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"12899_CR11","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jinf.2016.07.002","volume":"73","author":"MJ Satlin","year":"2016","unstructured":"Satlin MJ, Cohen N, Ma KC, Gedrimaite Z, Soave R, Askin G, Chen L, Kreiswirth BN, Walsh TJ, Seo SK. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies. J Infect. 2016;73(4):336\u201345.","journal-title":"J Infect"},{"issue":"21","key":"12899_CR12","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.3390\/jcm12216760","volume":"12","author":"HJ Jeon","year":"2023","unstructured":"Jeon HJ, Kang JM, Koh H, Kim MS, Ihn K. Postoperative bloodstream infection is associated with early vascular complications in pediatric liver transplant recipients with biliary Atresia. J Clin Med. 2023;12(21):6760.","journal-title":"J Clin Med"},{"key":"12899_CR13","doi-asserted-by":"publisher","first-page":"969117","DOI":"10.3389\/fcimb.2022.969117","volume":"12","author":"X Jian","year":"2023","unstructured":"Jian X, Du S, Zhou X, Xu Z, Wang K, Dong X, Hu J, Wang H. Development and validation of nomograms for predicting the risk probability of carbapenem resistance and 28-day all-cause mortality in gram-negative bacteremia among patients with hematological diseases. Front Cell Infect Microbiol. 2023;12:969117.","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"12899_CR14","doi-asserted-by":"publisher","first-page":"e15285","DOI":"10.1016\/j.heliyon.2023.e15285","volume":"9","author":"Y Liu","year":"2023","unstructured":"Liu Y, Liu Y, Liu Y, Chen X, Jia Y. Epidemiology, drug resistance analysis and mortality risk factor prediction of gram-negative bacteria infections in patients with allogeneic hematopoietic stem cell transplantation. Heliyon. 2023;9(4):e15285.","journal-title":"Heliyon"},{"key":"12899_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA. CDC\/NHSN surveillance definition of health careassociated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309\u201332.","journal-title":"Am J Infect Control"},{"key":"12899_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, et al. Multidrug- resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18:268\u201381.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"12899_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.diagmicrobio.2014.06.015","volume":"80","author":"Q Zeng","year":"2014","unstructured":"Zeng Q, Xu F, Jiang S. The impact of previous hospitalization in the preceding 90 days on the outcome in critically ill patients with gram-negative bloodstream infection. Diagn Microbiol Infect Dis. 2014;80(2):136\u201340.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"12899_CR18","doi-asserted-by":"publisher","first-page":"e00355","DOI":"10.1128\/AAC.00355-19","volume":"63","author":"DJ Diekema","year":"2019","unstructured":"Diekema DJ, Hsueh PR, Mendes RE, Pfaller MA, Rolston KV, Sader HS, Jones RN. The microbiology of bloodstream infection: 20-Year trends from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother. 2019;63(7):e00355\u201319.","journal-title":"Antimicrob Agents Chemother"},{"key":"12899_CR19","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2147\/IDR.S293290","volume":"14","author":"W Imtiaz","year":"2021","unstructured":"Imtiaz W, Syed Z, Rafaque Z, Andrews SC, Dasti JI. Analysis of antibiotic resistance and virulence traits (genetic and phenotypic) in Klebsiella pneumoniae clinical isolates from pakistan: identiffcation of Signiffcant levels of carbapenem and colistin resistance. Infect Drug Resist. 2021;14:227\u201336.","journal-title":"Infect Drug Resist"},{"issue":"11","key":"12899_CR20","doi-asserted-by":"publisher","first-page":"6673","DOI":"10.1128\/AAC.00984-16","volume":"60","author":"JY Lee","year":"2016","unstructured":"Lee JY, Kang CI, Ko JH, Lee WJ, Seok HR, Park GE, Cho SY, Ha YE, Chung DR, Lee NY, et al. Clinical features and risk factors for development of breakthrough Gram-Negative bacteremia during carbapenem therapy. Antimicrob Agents Chemother. 2016;60(11):6673\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"12899_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.3346\/jkms.2012.27.8.939","volume":"27","author":"SY Kim","year":"2012","unstructured":"Kim SY, Jung JY, Kang YA, Lim JE, Kim EY, Lee SK, Park SC, Chung KS, Park BH, Kim YS, et al. Risk factors for occurrence and 30-day mortality for carbapenem-resistant acinetobacter baumannii bacteremia in an intensive care unit. J Korean Med Sci. 2012;27:939\u201347.","journal-title":"J Korean Med Sci"},{"issue":"4","key":"12899_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jhin.2016.08.012","volume":"94","author":"\u00d6 Erg\u00f6n\u00fcl","year":"2016","unstructured":"Erg\u00f6n\u00fcl \u00d6, Aydin M, Azap A, Ba\u015faran S, Tekin S, Kaya \u015e, G\u00fcls\u00fcn S, Y\u00f6r\u00fck G, Kur\u015fun E, Ye\u015filkaya A, et al. Healthcare-associated Gram-negative bloodstream infections: antibiotic resistance and predictors of mortality. J Hosp Infect. 2016;94(4):381\u20135.","journal-title":"J Hosp Infect"},{"key":"12899_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijid.2015.06.024","volume":"37","author":"WI Sligl","year":"2015","unstructured":"Sligl WI, Dragan T, Smith SW. Nosocomial Gram-negative bacteremia in intensive care: epidemiology, antimicrobial susceptibilities, and outcomes. Int J Infect Dis. 2015;37:129\u201334.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"12899_CR24","doi-asserted-by":"publisher","first-page":"dlad096","DOI":"10.1093\/jacamr\/dlad096","volume":"5","author":"F Cogliati Dezza","year":"2023","unstructured":"Cogliati Dezza F, Covino S, Petrucci F, Sacco F, Viscido A, Gavaruzzi F, Ceccarelli G, Raponi G, Borrazzo C, Alessandri F, et al. Risk factors for carbapenem-resistant acinetobacter baumannii (CRAB) bloodstream infections and related mortality in critically ill patients with CRAB colonization. JAC Antimicrob Resist. 2023;5(4):dlad096.","journal-title":"JAC Antimicrob Resist"},{"issue":"2","key":"12899_CR25","doi-asserted-by":"publisher","first-page":"100283","DOI":"10.1016\/j.infpip.2023.100283","volume":"5","author":"JA Cortes","year":"2023","unstructured":"Cortes JA, Valderrama-Rios MC, Nocua-B\u00e1ez LC, Quiti\u00e1n LM, Lozada FA, Buitrago G. Effect of bloodstream infection on survival in COVID-19 patients admitted to an intensive care unit in colombia: a matched cohort analysis. Infect Prev Pract. 2023;5(2):100283.","journal-title":"Infect Prev Pract"},{"key":"12899_CR26","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1469-0691.2011.03606.x","volume":"18","author":"DC Lye","year":"2012","unstructured":"Lye DC, Earnest A, Ling ML, Lee TE, Yong HC, Fisher DA, Krishnan P, Hsu LY. The impact of multidrug resistance in healthcare-associated and nosocomial Gram-negative bacteraemia on mortality and length of stay: cohort study. Clin Microbiol Infect. 2012;18:502\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"12899_CR27","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s00134-022-06944-2","volume":"49","author":"A Tabah","year":"2023","unstructured":"Tabah A, Buetti N, Staiquly Q, Ruckly S, Akova M, Aslan AT, Leone M, Conway Morris A, Bassetti M, Arvaniti K, et al. Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study. Intensive Care Med. 2023;49:178\u201390.","journal-title":"Intensive Care Med"},{"issue":"4","key":"12899_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","volume":"21","author":"EM Trecarichi","year":"2015","unstructured":"Trecarichi EM, Pagano L, Candoni A, Pastore D, Cattaneo C, Fanci R, Fanci R, Nosari A, Caira M, Spadea A, Busca A, et al. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey. Clin Microbiol Infect. 2015;21(4):337\u201343.","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 2","key":"12899_CR29","doi-asserted-by":"publisher","first-page":"S174","DOI":"10.1093\/infdis\/jiz559","volume":"221","author":"T Xiao","year":"2020","unstructured":"Xiao T, Zhu Y, Zhang S, Wang Y, Shen P, Zhou Y, Zhou Y, Yu X, Xiao Y. A retrospective analysis of risk factors and outcomes of Carbapenem-Resistant Klebsiella pneumoniae bacteremia in nontransplant patients. J Infect Dis. 2020;221(Suppl 2):S174\u201383.","journal-title":"J Infect Dis"},{"issue":"Suppl 4","key":"12899_CR30","doi-asserted-by":"publisher","first-page":"S386","DOI":"10.1093\/cid\/ciaa1522","volume":"71","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Lin Q, Liu L, Ma R, Chen J, Shen Y, Zhu G, Jiang E, Mi Y, Han M, et al. Risk factors and outcomes of Antibiotic-resistant Pseudomonas aeruginosa bloodstream infection in adult patients with acute leukemia. Clin Infect Dis. 2020;71(Suppl 4):S386\u201393.","journal-title":"Clin Infect Dis"},{"key":"12899_CR31","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.jiph.2020.09.012","volume":"13","author":"G Zhang","year":"2020","unstructured":"Zhang G, Zhang M, Sun F, Zhou J, Wang Y, Zhu D, Chen Z, Chen Q, Chang Q, Liu H, et al. Epidemiology, mortality and risk factors for patients with K. Pneumoniae bloodstream infections: clinical impact of carbapenem resistance in a tertiary university teaching hospital of Beijing. J Infect Public Health. 2020;13:1710\u20134.","journal-title":"J Infect Public Health"},{"key":"12899_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijid.2021.03.004","volume":"106","author":"ZU Babar","year":"2021","unstructured":"Babar ZU, Dodani SK, Nasim A. Treatment outcome and adverse effects of colistin in adult patients with carbapenem-resistant Gram-negative bacteremia from Pakistan. Int J Infect Dis. 2021;106:171\u20135.","journal-title":"Int J Infect Dis"},{"issue":"7","key":"12899_CR33","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.cmi.2020.01.023","volume":"26","author":"M Giannella","year":"2020","unstructured":"Giannella M, Pascale R, Pancaldi L, Monari C, Ianniruberto S, Malosso P, Bussini L, Bartoletti M, Tedeschi S, Ambretti S, et al. Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study. Clin Microbiol Infect. 2020;26(7):897\u2013903.","journal-title":"Clin Microbiol Infect"},{"key":"12899_CR34","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/cid\/cis1006","volume":"56","author":"HS Ammerlaan","year":"2013","unstructured":"Ammerlaan HS, Harbarth S, Buiting AG, Crook DW, Fitzpatrick F, Hanberger H, Herwaldt LA, van Keulen PH, Kluytmans JA, Kola A, et al. Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. Clin Infect Dis. 2013;56:798\u2013805.","journal-title":"Clin Infect Dis"},{"key":"12899_CR35","doi-asserted-by":"publisher","first-page":"e02349","DOI":"10.1128\/AAC.02349-16","volume":"61","author":"MJ Satlin","year":"2017","unstructured":"Satlin MJ, Chen L, Patel G, Gomez-Simmonds A, Weston G, Kim AC, Seo SK, Rosenthal ME, Sperber SJ, Jenkins SG, et al. Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE epicenter of the united States. Antimicrob Agents Chemother. 2017;61:e02349\u201316.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"12899_CR36","doi-asserted-by":"publisher","first-page":"106284","DOI":"10.1016\/j.ijantimicag.2021.106284","volume":"57","author":"J Qu","year":"2021","unstructured":"Qu J, Feng C, Li H, Lv X. Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection. Int J Antimicrob Agents. 2021;57(3):106284.","journal-title":"Int J Antimicrob Agents"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12899-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12899-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12899-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:19:55Z","timestamp":1774351195000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12899-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12899"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12899-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Review Committee of Xiangya Third Hospital, Central South University approved the study (No. 24475). All methods were carried out in accordance with relevant guidelines and regulations. Informed consent was waived by the Ethics Review Committee of Xiangya Third Hospital, Central South University owing to the retrospective design. This study was conducted in full compliance with the ethical principles outlined in the Declaration of Helsinki for medical research involving human subjects. Participant confidentiality and data protection were maintained throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"614"}}